#United States #New York #Securities Fraud #Rosen Law Firm #Boston Scientific

Boston Scientific Investors Urged to Take Action

Overview

As the deadline approaches for Boston Scientific Corporation's (NYSE: BSX) investors, time is running out for those who purchased shares during the Class Period from July 23, 2025, to February 3, 2026. The Rosen Law Firm, a prominent player in investor rights, is reminding shareholders of the pressing opportunity to join a securities fraud class action lawsuit before the lead plaintiff deadline on May 4, 2026.

What’s at Stake?

The heart of the issue lies in claims that Boston Scientific misled investors regarding its U.S. Electrophysiology segment. During the class period, executives made upbeat announcements while simultaneously concealing significant negative information about their growth projections. This alarming discrepancy between public statements and private knowledge led to unexpected financial results and ultimately caused substantial losses for investors when the truth surfaced.

The Legal Path Forward

If you bought shares of Boston Scientific during the specified period, you may be eligible for compensation without incurring out-of-pocket expenses. This is contingent on representation by a qualified law firm that can navigate the complexities of securities class actions. To participate in the lawsuit, investors can visit Rosen Law Firm's website or contact attorney Phillip Kim at 866-767-3653.

Why Choose Rosen Law Firm?

Rosen Law Firm is recognized for its outstanding track record in representing investors in securities disputes. With a history of significant settlements, including the largest-ever settlement against a Chinese company, Rosen Law Firm stands out for its commitment to investor advocacy and its ability to recover substantial amounts for claimants. In 2019, the firm achieved over $438 million in settlements, showcasing its effectiveness and expertise in securities law.

Join the Class Action

It’s essential for affected investors to act swiftly. To serve as the lead plaintiff, individuals must file a motion with the court by May 4, 2026. As a lead plaintiff, you will represent the collective interests of all class members in guiding the lawsuit's trajectory. However, keep in mind that a certified class has not yet been established, and you may remain an absent class member if you choose to do so.

For more information and updates on the lawsuit, follow Rosen Law Firm on LinkedIn, Twitter, and Facebook.

Conclusion

For investors holding Boston Scientific shares, the time to act is now. Don’t miss out on the potential to recover losses due to alleged securities fraud. The Rosen Law Firm invites potential class members to join this important collective effort in seeking justice and accountability. Time is of the essence, and the firm’s experienced team is ready to advocate on behalf of investors.

• ---